Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: A midterm follow-up

Echocardiography

Volumn 22, Issue 2, 2005, Pages 105-109

  Veselka, Josef ^a   Procházková, Šárka ^a   Bolomová Homolová, Ingrid ^a   Duchoňová, Radka ^a   Tesař, David ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Alcohol septal ablation; Hypertrophic obstructive cardiomyopathy; Left ventricular remodeling; Nonsurgical septal reduction therapy; Percutaneous intervention

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; VERAPAMIL;

ADULT; AGED; ALCOHOL SEPTAL ABLATION; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEFIBRILLATOR; DOPPLER ECHOCARDIOGRAPHY; DOPPLER TEI INDEX; DYSPNEA; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART PERFORMANCE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PARAMETER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RELAXATION TIME; STATISTICAL SIGNIFICANCE; THICKNESS; TREATMENT OUTCOME;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 13444280032     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0742-2822.2005.03148.x     Document Type: Article

References (22)

1. Maron MS, Olivotto I, Betocchi S, et al: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303.
2. Sigwart U: Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
3. Lakkis NM, Nagueh SF, Killip D, et al: Nonsurgical septal reduction for symptomatic hypertrophic obstructive cardiomyopathy: The Baylor experience. J Interv Cardiol 2000;13:157-159.
4. Nagueh SF, Ommen SR, Lakkis NM, et al: Comparison of ethanol septal reduction therapy with surgical myectomy fort he treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-1706.
5. Shamim W, Yousufuddin M, Wang D, et al: Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med 2002;347:1326-1333.
6. Marian AJ: Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 2000;355:58-60.
7. Nagueh SF, Bachinski LL, Meyer D, et al: Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-130.
8. Nagueh SF, Lakkis NM, Middleton KJ, et al: Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1999;34:1123-1128.
9. Veselka J, Tesař D, Honěk T: Left ventricular remodeling and improvement of left ventricular relaxation after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Am J Cardiol 2002;90(Suppl 6A):140H.
10. Tei C, Dujardin KS, Hodge DO, et al: Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996;28:658-664.
11. Veselka J, Honěk T: The management of hypertrophic obstructive cardiomyopathy: The role of percutaneous transluminal septal myocardial ablation. Cardiol 2000;9:335-340.
12. Moller JE, Sondertgaard E, Poulsen SH, et al: Serial Doppler echocardiographic assessment of left and right ventricular performance after first myocardial infarction. J Am Soc Echocardiogr 2001;14:249-255.
13. Moller JE, Sondergaard E, Poulsen SH, et al: The Doppler echocardiographic myocardial index predicts left-ventricular dilation and cardiac death after myocardial infarction. Cardiology 2001;95:105-111.
14. Poulsen SH, Jensen SE, Seward JB, et al: Value of Doppler index of myocardial performance in the early phase of acute myocardial infarction. J Am Soc Echocardiogr 2000;13:723-730.
15. Vivekananthan K, Kalapura T, Mehra MR, et al: Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Am J Cardiol 2002;90:517-520.
16. Zhang H, Otsuji Y, Matsukida K, et al: Noninvasive differentiation of normal from pseudonormal/restrictive mitral flow using Tei index combining systolic and diastolic function. Circ J 2002;66:831-836.
17. Harjai KJ, Scott L, Vivekananthan K, et al: The Tei index: A new prognostic index for patients with symptomatic heart failure. J Am Soc Echocardiogr 2002;15:864-868.
18. Bruch C, Schmermund A, Marin D, et al: Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J 2000;22:1888-1895.
19. Moller JE, Poulsen SH, Egstrup K: Effect of preload alterations on a new Doppler echocardiographic index of combined systolic and diastolic performance. J Am Soc Echocardiogr 1999;12:1065-1072.
20. Poulsen SH, Nielsen JC, Andersen HR: The influence of heart rate on the Doppler-derived myocardial performance index. J Am Soc Echocardiogr 2000;13:379-384.
21. Veselka J, Tesař D, Urbanovǎ T, et al: Improvement of index of myocardial performance after percutaneous transluminal septal myocardial ablation (PTSMA) for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2002;39(Suppl B):22B-23B.
22. Flores-Ramirez R, Lakkis NM, Middleton KJ, et al: Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;37:208-14.